пятница, 25 ноября 2016 г.

J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg

J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg


Nov 24 U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday, citing people it said were familiar with the matter. The report said that deliberations are still at an early stage following Johnson & Johnson's initial offer, and Actelion is working with an adviser to explore options.



from Biotech News